Literature DB >> 15067651

Secondary reconstruction of the extensor mechanism using part of the quadriceps tendon, patellar retinaculum, and Gore-Tex strips after proximal tibial resection.

Yehuda Kollender1, Benjamin Bender, Avi A Weinbroum, Alexander Nirkin, Isaac Meller, Jacob Bickels.   

Abstract

Competence of the extensor mechanism is the major determinant of functional outcome of patients after proximal tibia resection. A method of secondary reconstruction of the extensor mechanism using the middle third of the quadriceps tendon and the patellar retinaculum augmented with Gore-Tex strips and gastrocnemius flap is described. Between 1981 and 1997, 7 patients with extension lag greater than 20 degrees at least 1 year after the initial surgery underwent secondary reconstruction of the extensor mechanism. All patients were followed up for a minimum of 2 years. Full extension to an extension lag of 10 degrees was achieved in three patients, and an extension lag between 10 degrees and 20 degrees was achieved in 4 patients. All patients had good to excellent functional outcomes and reported no limitations in daily life activities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067651     DOI: 10.1016/j.arth.2003.11.004

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

Review 1.  [Reconstruction of the extensor tendons in revision total knee arthroplasty and tumor surgery].

Authors:  L Gerdesmeyer; H Gollwitzer; P Diehl; R Burgkart; E Steinhauser
Journal:  Orthopade       Date:  2006-02       Impact factor: 1.087

2.  Protecting a patellar ligament reconstruction after proximal tibial resection: a simplified approach.

Authors:  Vijay Titus; Mark Clayer
Journal:  Clin Orthop Relat Res       Date:  2008-04-19       Impact factor: 4.176

Review 3.  [Quadriceps tendon insufficiency and rupture : Treatment options in total knee arthroplasty].

Authors:  K Thiele; P von Roth; T Pfitzner; B Preininger; C Perka
Journal:  Orthopade       Date:  2016-05       Impact factor: 1.087

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.